Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Department I for Internal Medicine, ECMM Excellence Centre of Medical Mycology, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Infection. 2018 Dec;46(6):897-899. doi: 10.1007/s15010-018-1218-1. Epub 2018 Sep 14.
Due to the increase of severely immunocompromised patients, of invasive procedures including central intravascular catheters, and of the use of broad-spectrum antibiotics, the incidence of Candida bloodstream infections has risen intensely in the last decades. Candida bloodstream infection is a serious disease with high mortality. Optimized diagnostic and therapeutic management can improve outcome. Thus, the aim of our mini-review is to highlight important and often missed opportunities in the management of Candida bloodstream infection.
We searched the published literature and describe the essentials in the management of Candida bloodstream infection.
Four essentials were identified: (1) isolation of Candida spp. from a blood culture should always be considered relevant and requires treatment. Daily blood cultures should be drawn to determine cessation of candidemia. (2) Central venous catheter (CVC) and/or other indwelling devices should be removed. (3) Echinocandins are the first choice. Antifungal treatment should be continued for at least 14 days after cessation of fungemia. Susceptibility testing should be performed to identify resistance and to facilitate transition to oral treatment. (4) In persistent candidemia, echocardiography is an important investigation; ophthalmoscopy should be considered.
Further efforts should be undertaken to increase the adherence to the essentials in the management of Candia bloodstream infection.
由于严重免疫功能低下患者的增加、包括中心血管内导管在内的侵袭性操作的增加以及广谱抗生素的使用,念珠菌血流感染的发病率在过去几十年中急剧上升。念珠菌血流感染是一种死亡率很高的严重疾病。优化的诊断和治疗管理可以改善预后。因此,我们的小型综述旨在强调念珠菌血流感染管理中经常被忽视的重要机会。
我们搜索了已发表的文献,并描述了念珠菌血流感染管理中的要点。
确定了四个要点:(1)从血培养中分离出念珠菌 spp. 应始终被认为具有相关性,并需要治疗。应每天抽取血培养以确定菌血症的停止。(2)应移除中央静脉导管 (CVC) 和/或其他留置装置。(3)棘白菌素类是首选药物。抗真菌治疗应在菌血症停止后至少持续 14 天。应进行药敏试验以确定耐药性,并有助于过渡到口服治疗。(4)在持续性念珠菌血症中,超声心动图是一项重要的检查;应考虑进行眼底检查。
应进一步努力提高对念珠菌血流感染管理要点的遵守程度。